<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of Clinical and Experimental Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Annals of Clinical and Experimental Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Анналы клинической и экспериментальной неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-5473</issn><issn publication-format="electronic">2409-2533</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1514</article-id><article-id pub-id-type="doi">10.17816/ACEN.1514</article-id><article-id pub-id-type="edn">PVYHJZ</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Limbic system changes in Huntington's disease: diffusion tensor MRI data with ROI analysis</article-title><trans-title-group xml:lang="ru"><trans-title>Состояние лимбической системы при болезни Гентингтона: данные диффузионно-тензорной магнитно-резонансной томографии с ROI-анализом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-2447-1418</contrib-id><name-alternatives><name xml:lang="en"><surname>Anikin</surname><given-names>Georgy A.</given-names></name><name xml:lang="ru"><surname>Аникин</surname><given-names>Георгий Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Postgraduate Student, 5th Neurology Department, Institute of Clinical and Preventive Neurology</p></bio><bio xml:lang="ru"><p>аспирант 5-го неврологического отделения Института клинической и профилактической неврологии</p></bio><email>dante3red@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5706-6997</contrib-id><name-alternatives><name xml:lang="en"><surname>Filatov</surname><given-names>Alexey S.</given-names></name><name xml:lang="ru"><surname>Филатов</surname><given-names>Алексей Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Radiologist, Radiology Department</p></bio><bio xml:lang="ru"><p>канд. мед. наук, врач-рентгенолог отделения лучевой диагностики</p></bio><email>dante3red@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8062-0784</contrib-id><name-alternatives><name xml:lang="en"><surname>Liaskovik</surname><given-names>Alina A.</given-names></name><name xml:lang="ru"><surname>Лясковик</surname><given-names>Алина Анатольевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Radiologist, Radiology Department</p></bio><bio xml:lang="ru"><p>врач-рентгенолог отделения лучевой диагностики</p></bio><email>dante3red@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8752-7045</contrib-id><name-alternatives><name xml:lang="en"><surname>Klyushnikov</surname><given-names>Sergey A.</given-names></name><name xml:lang="ru"><surname>Клюшников</surname><given-names>Сергей Анатольевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Leading Researcher, 5th Neurology Department, Institute of Clinical and Preventive Neurology</p></bio><bio xml:lang="ru"><p>канд. мед. наук, в. н. с. 5-го неврологического отделения Института клинической и профилактической неврологии</p></bio><email>dante3red@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9419-1159</contrib-id><name-alternatives><name xml:lang="en"><surname>Abramycheva</surname><given-names>Nataliya Y.</given-names></name><name xml:lang="ru"><surname>Абрамычева</surname><given-names>Наталья Юрьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biol.), Senior Researcher, Head, Molecular Genetics Laboratory, 5th Neurology Department, Institute of Clinical and Preventive Neurology</p></bio><bio xml:lang="ru"><p>канд. биол. наук, в. н. с., зав. молекулярно-генетической лабораторией 5-го неврологического отделения Института клинической и профилактической неврологии</p></bio><email>dante3red@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2704-6282</contrib-id><name-alternatives><name xml:lang="en"><surname>Illarioshkin</surname><given-names>Sergey N.</given-names></name><name xml:lang="ru"><surname>Иллариошкин</surname><given-names>Сергей Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Professor, Full Member of the RAS, Director, Brain Institute, Deputy Director for Science; Head, Neurology Department</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор, академик РАН, директор Института мозга, зам. директора по научной работе; зав. кафедрой неврологии</p></bio><email>annaly-nevrologii@neurology.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian Center of Neurology and Neurosciences</institution></aff><aff><institution xml:lang="ru">Российский центр неврологии и нейронаук</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">The Russian University of Medicine</institution></aff><aff><institution xml:lang="ru">Российский университет медицины</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2026-09-30" publication-format="electronic"><day>30</day><month>09</month><year>2026</year></pub-date><volume>20</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>13</fpage><lpage>28</lpage><history><date date-type="received" iso-8601-date="2026-04-24"><day>24</day><month>04</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-06-18"><day>18</day><month>06</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Anikin G.A., Filatov A.S., Liaskovik A.A., Klyushnikov S.A., Abramycheva N.Y., Illarioshkin S.N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Аникин Г.А., Филатов А.С., Лясковик А.А., Клюшников С.А., Абрамычева Н.Ю., Иллариошкин С.Н.</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Anikin G.A., Filatov A.S., Liaskovik A.A., Klyushnikov S.A., Abramycheva N.Y., Illarioshkin S.N.</copyright-holder><copyright-holder xml:lang="ru">Аникин Г.А., Филатов А.С., Лясковик А.А., Клюшников С.А., Абрамычева Н.Ю., Иллариошкин С.Н.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://annaly-nevrologii.com/pathID/article/view/1514">https://annaly-nevrologii.com/pathID/article/view/1514</self-uri><abstract xml:lang="en"><p><bold>Introduction.</bold> Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder in which early affective and cognitive symptoms may be associated with limbic system involvement; however, the pattern of microstructural changes in its major white matter pathways remains insufficiently understood.</p> <p><bold>The</bold> <bold>aim</bold> of the study was to assess the state of limbic system tracts (cingulum, fornix, and inferior longitudinal fasciculus) in patients at manifest and premanifest stages of HD using diffusion tensor MRI (DT-MRI) and region-of-interest (ROI) analysis.</p> <p><bold>Materials and methods</bold><bold>.</bold> A total of 64 individuals were examined: 24 patients with manifest HD, 20 premanifest mutation carriers, and 20 healthy volunteers matched for sex and age. All subjects underwent DT-MRI on a Siemens Magnetom Prisma 3T scanner (64 diffusion directions, <italic>b</italic>-values 1000 and 2500 s/mm<sup>2</sup>), followed by data adjustment and normalization to MNI space. ROI analysis of the cingulum, fornix, and inferior longitudinal fasciculus was performed using DSI Studio software, extracting fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD). Correlations with clinical scales (UHDRS, MoCA, FAB, HADS, Schulte tables) and genetic markers (CAG repeat length, CAP score) were assessed.</p> <p><bold>Results.</bold> In manifest patients, the cingulum showed decreased FA and increased RD, indicating predominant demyelination, whereas the inferior longitudinal fasciculus exhibited concurrent increases in both AD and RD, suggesting more severe axonal and myelin damage. In premanifest mutation carriers, the earliest changes were detected in the fornix crura (decreased FA) and in the anterior portion of the inferior longitudinal fasciculus (increased RD and MD). Significant correlations were found between diffusion metrics and anxiety and depression scores (HADS), cognitive performance (MoCA, FAB), and genetic burden (CAG repeat length, CAP score).</p> <p><bold>Conclusion.</bold> These findings confirm the heterogeneous and stage-dependent nature of limbic tract involvement in HD, supporting the potential use of DT-MRI as a tool for preclinical diagnosis and monitoring of non-motor manifestations of the disease.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение</bold><bold>.</bold> Болезнь Гентингтона (БГ) — аутосомно-доминантное нейродегенеративное заболевание, при котором ранние аффективные и когнитивные нарушения могут быть связаны с поражением лимбической системы, однако характер микроструктурных изменений её ключевых проводящих путей остаётся недостаточно изученным.</p> <p><bold>Целью </bold>исследования являлась оценка состояния трактов лимбической системы (поясного пучка, свода и нижнего продольного пучка) у пациентов на манифестной и доклинической стадиях БГ с помощью диффузионно-тензорной магнитно-резонансной томографии (ДТ-МРТ) и ROI-анализа.</p> <p><bold>Материалы и методы</bold><bold>.</bold> Обследованы 64 человека: 24 пациента с манифестной БГ, 20 доклинических носителей мутации в гене HTT и 20 здоровых добровольцев, сопоставимых по полу и возрасту. Всем выполнена ДТ-МРТ на томографе «Siemens Magnetom Prisma» (3 Тл, 64 направления, <italic>b</italic> = 1000 и 2500 с/мм<sup>2</sup>) с последующей коррекцией данных и нормализацией к пространству MNI. Проводили ROI-анализ поясного пучка, свода и нижнего продольного пучка в программном обеспечении «DSI Studio» с извлечением метрик: фракционная анизотропия (FA), средняя диффузия (MD), аксиальная (AD) и радиальная (RD) диффузия. Оценивали корреляции с клиническими шкалами (UHDRS, MoCA, FAB, HADS, таблицы Шульте) и генетическими маркерами (число CAG-повторов, CAP-индекс).</p> <p><bold>Результаты.</bold> У манифестных пациентов в поясном пучке выявлено снижение FA и повышение RD, что указывает на преобладание демиелинизации, в то время как в нижнем продольном пучке наблюдалось сочетанное повышение AD и RD, свидетельствующее о более грубом аксонально-миелиновом повреждении. У доклинических носителей мутации наиболее ранние изменения зафиксированы в ножках свода в виде снижения FA, а также в передних отделах нижнего продольного пучка в виде повышения RD и MD. Выявлены значимые корреляции диффузионных метрик с показателями тревоги и депрессии (HADS), когнитивными функциями (MoCA, FAB), а также генетической нагрузкой (число CAG-повторов, CAP-индекс).</p> <p><bold>Заключение.</bold> Полученные данные подтверждают гетерогенный и стадиозависимый характер поражения лимбических трактов при БГ, что открывает перспективы для использования ДТ-МРТ в качестве инструмента доклинической диагностики и мониторинга немоторных проявлений заболевания.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Huntington's disease</kwd><kwd>limbic system</kwd><kwd>diffusion tensor magnetic resonance imaging</kwd><kwd>tractography</kwd><kwd>biomarkers</kwd><kwd>affective disorders</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>болезнь Гентингтона</kwd><kwd>лимбическая система</kwd><kwd>диффузионно-тензорная магнитно-резонансная томография</kwd><kwd>трактография</kwd><kwd>биомаркеры</kwd><kwd>аффективные нарушения</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Scahill RI, Zeun P, Osborne-Crowley K, et al. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington’s disease Young Adult Study (HD-YAS): a cross-sectional analysis. Lancet Neurol. 2020;19(6):502–512. doi: 10.1016/S1474-4422(20)30143-5</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>McColgan P, Seunarine KK, Razi A, et al. Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington’s disease. Brain. 2015;138(Pt 11):3327–3344. doi: 10.1093/brain/awv259</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Poudel GR, Harding IH, Egan GF, Georgiou-Karistianis N. Network spread determines severity of degeneration and disconnection in Huntington’s disease. Hum Brain Mapp. 2019;40(14):4192–4201. doi: 10.1002/hbm.24695</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Pini L, Jacquemot C, Cagnin A, et al. Aberrant brain network connectivity in presymptomatic and manifest Huntington’s disease: a systematic review. Hum Brain Mapp. 2020;41(1):256–269. doi: 10.1002/hbm.24790</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Coppen EM, van der Grond J, Hart EP, et al. The visual cortex and visual cognition in Huntington’s disease: an overview of current literature. Behav Brain Res. 2018;351:63–74. doi: 10.1016/j.bbr.2018.05.019</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Bohanna I, Georgiou-Karistianis N, Sritharan A, et al. Diffusion tensor imaging in Huntington’s disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits. Brain Imaging Behav. 2011;5(3):171–180. doi: 10.1007/s11682-011-9121-8</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kinnunen KM, Mullin AP, Pustina D, et al. Recommendations to optimize the use of volumetric MRI in Huntington’s disease clinical trials. Front Neurol. 2021;12:712565. doi: 10.3389/fneur.2021.712565</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Gabery S, Kwa JE, Cheong RY, et al. Early white matter pathology in the fornix of the limbic system in Huntington disease. Acta Neuropathol. 2021;142(5):791–806. doi: 10.1007/s00401-021-02362-8</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Azevedo P, Piovesana L, Nogueira M, et al. White matter microstructural alterations in Huntington disease: when neurodegeneration starts? [abstract]. Mov Disord. 2018;33(suppl 2).</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Della Nave R, Ginestroni A, Tessa C, et al. Regional distribution and clinical correlates of white matter structural damage in Huntington disease: a tract-based spatial statistics study. AJNR Am J Neuroradiol. 2010;31(9):1675–1681. doi: 10.3174/ajnr.A2128</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Irfanoglu MO, Sarlls J, Nayak A, Pierpaoli C. Evaluating corrections for Eddy-currents and other EPI distortions in diffusion MRI: methodology and a dataset for benchmarking. Magn Reson Med. 2019;81(4):2774–2787. doi: 10.1002/mrm.27577</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Yeh FC. DSI Studio: an integrated tractography platform and fiber data hub for accelerating brain research. Nat Methods. 2025;22(8):1617–1619. doi: 10.1038/s41592-025-02762-8</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Yeh FC, Panesar S, Fernandes D, et al. Population-averaged atlas of the macroscale human structural connectome and its network topology. Neuroimage. 2018;178:57–68. doi: 10.1016/j.neuroimage.2018.05.027</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Ponomareva N, Klyushnikov S, Abramycheva N, et al. Alpha-theta border EEG abnormalities in preclinical Huntington’s disease. J Neurol Sci. 2014;344(1-2):114–120. doi: 10.1016/j.jns.2014.06.035</mixed-citation></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Seliverstova EV, Seliverstov YuА, Konovalov RN, Illarioshkin SN. Resting-state functional magnetic resonance imaging: new possibilities for studying brain physiology and pathology. Annals of Clinical and Experimental Neurology. 2013;7(4):39–44. doi:10.17816/psaic218</mixed-citation><mixed-citation xml:lang="ru">Селиверстова Е.В., Селиверстов Ю.А., Коновалов Р.Н., Иллариошкин С.Н. Функциональная магнитно-резонансная томография покоя: новые возможности изучения физиологии и патологии мозга. Анналы клинической и экспериментальной неврологии. 2013;7(4):39–44.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><mixed-citation>Clark ML, Abimanyi-Ochom J, Le H, et al. A systematic review and meta-analysis of depression and apathy frequency in adult-onset Huntington’s disease. Neurosci Biobehav Rev. 2023;149:105166. doi: 10.1016/j.neubiorev.2023.105166</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Estevez-Fraga C, Elmalem MS, Papoutsi M, et al. Progressive alterations in white matter microstructure across the timecourse of Huntington’s disease. Brain Behav. 2023;13(4):e2940. doi: 10.1002/brb3.2940.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Phillips O, Squitieri F, Sanchez-Castaneda C, et al. Deep white matter in Huntington’s disease. PLoS One. 2014;9(10):e109676. doi: 10.1371/journal.pone.0109676</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Gregory S, Johnson E, Byrne LM, et al. Characterizing white matter in Huntington’s disease. Mov Disord Clin Pract. 2019;7(1):52–60. doi: 10.1002/mdc3.12866</mixed-citation></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Illarioshkin SN. Early (pre-dementia) forms of cognitive disorders. Consilium Medicum. 2007;9(2):107–111.</mixed-citation><mixed-citation xml:lang="ru">Иллариошкин С.Н. Ранние (додементные) формы когнитивных расстройств. Consilium Medicum. 2007;9(2):107–111.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><mixed-citation>Vidas-Guscic N, van Rijswijk J, Van Audekerke J, et al. Diffusion MRI marks progressive alterations in fiber integrity in the zQ175DN mouse model of Huntington’s disease. Neurobiol Dis. 2024;193:106438. doi: 10.1016/j.nbd.2024.106438</mixed-citation></ref></ref-list></back></article>
